- call +1-201-465-4211
- email sales@mrinsights.biz
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Scope of the Report:
The worldwide market for Anti-Venom is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Anti-Venom in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Medtoxin Venom Laboratories
Institute of Immunology
Alomone Labs
Sigma Aldrich
Wyeth Pharmaceuticals
Protherics PLC
Bharat Serums and Vaccines
Butantan Institute
Haffkine Bio-Pharmaceutical Corporation
Micropaharm Limited
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cytotoxic
Neurotoxic
Haemotoxic
Cardiotoxic
Myotoxic
Market Segment by Applications, can be divided into
Snake
Spider
Scorpion
There are 15 Chapters to deeply display the global Anti-Venom market.
Chapter 1, to describe Anti-Venom Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Venom, with sales, revenue, and price of Anti-Venom, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Venom, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Venom market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Venom sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti-Venom Introduction
1.2 Market Analysis by Type
1.2.1 Cytotoxic
1.2.2 Neurotoxic
1.2.3 Haemotoxic
1.2.4 Cardiotoxic
1.2.5 Myotoxic
1.3 Market Analysis by Applications
1.3.1 Snake
1.3.2 Spider
1.3.3 Scorpion
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medtoxin Venom Laboratories
2.1.1 Business Overview
2.1.2 Anti-Venom Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Medtoxin Venom Laboratories Anti-Venom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Institute of Immunology
2.2.1 Business Overview
2.2.2 Anti-Venom Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Institute of Immunology Anti-Venom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Alomone Labs
2.3.1 Business Overview
2.3.2 Anti-Venom Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Alomone Labs Anti-Venom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sigma Aldrich
2.4.1 Business Overview
2.4.2 Anti-Venom Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sigma Aldrich Anti-Venom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Wyeth Pharmaceuticals
2.5.1 Business Overview
2.5.2 Anti-Venom Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Wyeth Pharmaceuticals Anti-Venom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Protherics PLC
2.6.1 Business Overview
2.6.2 Anti-Venom Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Protherics PLC Anti-Venom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bharat Serums and Vaccines
2.7.1 Business Overview
2.7.2 Anti-Venom Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bharat Serums and Vaccines Anti-Venom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Butantan Institute
2.8.1 Business Overview
2.8.2 Anti-Venom Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Butantan Institute Anti-Venom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Haffkine Bio-Pharmaceutical Corporation
2.9.1 Business Overview
2.9.2 Anti-Venom Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Haffkine Bio-Pharmaceutical Corporation Anti-Venom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Micropaharm Limited
2.10.1 Business Overview
2.10.2 Anti-Venom Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Micropaharm Limited Anti-Venom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-Venom Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-Venom Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-Venom Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Venom Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-Venom Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-Venom Market Analysis by Regions
4.1 Global Anti-Venom Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Venom Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-Venom Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-Venom Sales and Growth Rate (2013-2018)
4.3 Europe Anti-Venom Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-Venom Sales and Growth Rate (2013-2018)
4.5 South America Anti-Venom Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-Venom Sales and Growth Rate (2013-2018)
5 North America Anti-Venom by Countries
5.1 North America Anti-Venom Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-Venom Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-Venom Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-Venom Sales and Growth Rate (2013-2018)
5.3 Canada Anti-Venom Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-Venom Sales and Growth Rate (2013-2018)
6 Europe Anti-Venom by Countries
6.1 Europe Anti-Venom Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-Venom Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-Venom Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-Venom Sales and Growth Rate (2013-2018)
6.3 UK Anti-Venom Sales and Growth Rate (2013-2018)
6.4 France Anti-Venom Sales and Growth Rate (2013-2018)
6.5 Russia Anti-Venom Sales and Growth Rate (2013-2018)
6.6 Italy Anti-Venom Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-Venom by Countries
7.1 Asia-Pacific Anti-Venom Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-Venom Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-Venom Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-Venom Sales and Growth Rate (2013-2018)
7.3 Japan Anti-Venom Sales and Growth Rate (2013-2018)
7.4 Korea Anti-Venom Sales and Growth Rate (2013-2018)
7.5 India Anti-Venom Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-Venom Sales and Growth Rate (2013-2018)
8 South America Anti-Venom by Countries
8.1 South America Anti-Venom Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-Venom Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-Venom Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-Venom Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-Venom Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-Venom Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-Venom by Countries
9.1 Middle East and Africa Anti-Venom Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-Venom Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-Venom Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-Venom Sales and Growth Rate (2013-2018)
9.3 UAE Anti-Venom Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-Venom Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-Venom Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-Venom Sales and Growth Rate (2013-2018)
10 Global Anti-Venom Market Segment by Type
10.1 Global Anti-Venom Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-Venom Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-Venom Revenue and Market Share by Type (2013-2018)
10.2 Cytotoxic Sales Growth and Price
10.2.1 Global Cytotoxic Sales Growth (2013-2018)
10.2.2 Global Cytotoxic Price (2013-2018)
10.3 Neurotoxic Sales Growth and Price
10.3.1 Global Neurotoxic Sales Growth (2013-2018)
10.3.2 Global Neurotoxic Price (2013-2018)
10.4 Haemotoxic Sales Growth and Price
10.4.1 Global Haemotoxic Sales Growth (2013-2018)
10.4.2 Global Haemotoxic Price (2013-2018)
10.5 Cardiotoxic Sales Growth and Price
10.5.1 Global Cardiotoxic Sales Growth (2013-2018)
10.5.2 Global Cardiotoxic Price (2013-2018)
10.6 Myotoxic Sales Growth and Price
10.6.1 Global Myotoxic Sales Growth (2013-2018)
10.6.2 Global Myotoxic Price (2013-2018)
11 Global Anti-Venom Market Segment by Application
11.1 Global Anti-Venom Sales Market Share by Application (2013-2018)
11.2 Snake Sales Growth (2013-2018)
11.3 Spider Sales Growth (2013-2018)
11.4 Scorpion Sales Growth (2013-2018)
12 Anti-Venom Market Forecast (2018-2023)
12.1 Global Anti-Venom Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-Venom Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-Venom Market Forecast (2018-2023)
12.2.2 Europe Anti-Venom Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-Venom Market Forecast (2018-2023)
12.2.4 South America Anti-Venom Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-Venom Market Forecast (2018-2023)
12.3 Anti-Venom Market Forecast by Type (2018-2023)
12.3.1 Global Anti-Venom Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-Venom Market Share Forecast by Type (2018-2023)
12.4 Anti-Venom Market Forecast by Application (2018-2023)
12.4.1 Global Anti-Venom Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-Venom Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-Venom Picture
Table Product Specifications of Anti-Venom
Figure Global Sales Market Share of Anti-Venom by Types in 2017
Table Anti-Venom Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
